Cardiac Amyloidosis-Challenging Diagnosis and Unclear Clinical Picture
Cardiac amyloidosis (CA) is a rare systemic disease determined by the extracellular deposition of amyloid protein in the heart. The protein can accumulate in any part of the heart: myocardium, vessels, endocardium, valves, epicardium and parietal pericardium. The types of CA include the following ty...
Main Authors: | Sylwia Kozak, Krzysztof Ulbrich, Maciej Migacz, Krzysztof Szydło, Katarzyna Mizia-Stec, Michał Holecki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/5/450 |
Similar Items
-
Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic
by: Krister Lindmark, et al.
Published: (2021-02-01) -
Transthyretin cardiac amyloidosis: an update on diagnosis and treatment
by: Hiroyuki Yamamoto, et al.
Published: (2019-12-01) -
Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis
by: Richard K. Cheng, MD, MSc, et al.
Published: (2020-09-01) -
Through thick and thin: Diagnosis of transthyretin cardiac amyloidosis through non-invasive multimodality imaging
by: Abidin, HAZ, et al.
Published: (2021) -
Through thick and thin: Diagnosis of transthyretin cardiac amyloidosis through non-invasive multimodality imaging
by: Kasim, S., et al.
Published: (2021)